Riskpilot← Back to searchSign inGet full accessBiotronik AB
ABActiveOrg 5568417553Olstorpsvägen 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 20111 employees
Revenue 2024
SEK 28,9M
-10% vs 2023
EBITDA margin
4.6%
-12% vs 2023
Equity ratio
55.9%
Financial strength
Net profit 2024
SEK 950K
-14% vs 2023
| Revenue | SEK 28,9M | -10% |
| EBITDA | SEK 1,3M | -12% |
| Net profit | SEK 950K | -14% |
| Total assets | SEK 14,4M | +1% |
| Equity | SEK 8,1M | +13% |
| Employees | 1 | — |
Legal name
Biotronik AB
Org number
5568417553
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
10 februari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Belke, Mario Roberto Madsen, Niels Jörn
Company purpose
Föremålet för bolagets verksamhet är försäljning, produkt- utbildning, teknisk support och workshops inom området medicinsk teknik, med särskild fokus på kärlintervention och hjärt elektroterapi, antingen direkt eller genom dotterbolag samt annan därmed förenlig verksamhet.
Address
Olstorpsvägen 4
Email
biotronik.danmark@biotronik.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 29 927 | 31 721 | 32 221 | 29 527 | 32 304 | 32 146 | 28 865 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 625 | 996 | 1 087 | 927 | 1 444 | 980 | 1 709 | 1 786 | 1 516 | 1 341 |
| Depreciation & amort. | −9 | −5 | −6 | −4 | −207 | −205 | −165 | −128 | −174 | −173 |
| EBIT | 616 | 991 | 1 081 | 923 | 1 237 | 775 | 1 544 | 1 658 | 1 342 | 1 168 |
| Net financials | — | −5 | −1 | — | −11 | −6 | −59 | −32 | 51 | 38 |
| Profit before tax | 616 | 987 | 1 081 | 924 | 1 227 | 769 | 1 485 | 1 626 | 1 393 | 1 206 |
| Tax | −145 | −227 | −248 | −212 | −280 | −173 | −312 | −347 | −291 | −256 |
| Net profit | 471 | 760 | 833 | 712 | 947 | 596 | 1 173 | 1 279 | 1 102 | 950 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9 331 | 9 436 | 17 925 | 14 491 | 14 650 | 14 083 | 18 516 | 14 604 | 14 265 | 14 419 |
| Equity | 4 707 | 5 467 | 6 300 | 7 011 | 7 958 | 8 554 | 9 727 | 6 005 | 7 107 | 8 058 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 174 | 80 | 0 | 0 |
| Short-term debt | 4 624 | 3 969 | 11 625 | 7 480 | 6 692 | 5 529 | 8 615 | 8 519 | 7 158 | 6 362 |
| Total debt | 4 624 | 3 969 | 11 625 | 7 480 | 6 692 | 5 529 | 8 789 | 8 599 | 7 158 | 6 362 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20152024
Equity ratio
55.9%
This company
38.2%
Market median
+46% vs market
20152024
Return on equity
11.8%
This company
18.4%
Market median
+36% vs market
20152024
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20152024
Asset turnover
2.00×
This company
1.12×
Market median
+79% vs market
20152024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NJ External Signatory | External Signatory | 2020 | — | — |
ZS Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
IC Authorized Recipient of Service | Authorized Recipient of Service | 2020 | — | — |
AF Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BIOTRONIK INTERNATIONAL VERTRIEBS AG | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOTRONIK INTERNATIONAL VERTRIEBS AG
Biotronik AB (this company)Board members of Biotronik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Jörn Madsen | External Signatory | 0 companies |
| Zlatibor Sinik | Authorized Recipient of Service | 0 companies |
| Mario Roberto Belke | Chief Executive Officer | 0 companies |
| Iren Carlsson | Authorized Recipient of Service | 0 companies |
| Anders Fredrik Pålsson | Chief Auditor | 0 companies |
| Dirk Lars Schmerl | Board of Directors | 0 companies |
| Robert Nitsche | Board of Directors | 0 companies |
| Udo Tegtmeyer | Chairman | 0 companies |